Nvest Wealth Strategies’s ResMed RMD Stock Holding History

Nvest Wealth Strategies’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4	Closed	-$898	–	414
2026 Q1	$898	Buy	+4	New	+$997	﹤0.01%	231

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nvest Wealth Strategies's RMD Position: Q2 2026 in Review

Nvest Wealth Strategies sold out of ResMed (RMD) in Q2 2026, closing a stake of 4 shares — an estimated $898 sold.

Nvest Wealth Strategies first reported a position in RMD in Q1 2026 and held it in 1 quarter. The position peaked at $898 in Q1 2026. 448 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Nvest Wealth Strategies reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Nvest Wealth Strategies sold 4 ResMed shares in Q2 2026, an estimated $898.
Nvest Wealth Strategies first reported a position in ResMed in Q1 2026 and held it in 1 quarter.
Nvest Wealth Strategies's ResMed position peaked at $898 in Q1 2026.
448 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Nvest Wealth Strategies's 13F filing for Q2 2026, filed 10 Jul 2026.